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the the dominant Cranio-Caudal(CC) direction of motion were 
optimized for 4 NSCLC lung cancer patients in Pinnacle v9.1. 
The plans were made on mid-position CT with iGTV density 
override, spot size σ =6 mm and spot spacing 1σ. The total 
prescribed dose was 66Gy in 24 fractions to be delivered to 
>95% of planning target volume (PTV). The fractionated 
proton treatment delivery was simulated by an in-house 
developed time dependent simulation algorithm which 
integrates 4D deformation vector field (DVF) and realistic 
respiratory trace determined from CBCT images. The DVF 
describes the anatomical changes of each point over the 
respiratory cycle as a cyclic function. Each cycle is 
synchronously modified with the phase, scale and offset 
information from the real respiratory trace. The impact of 
the interplay effect in our simulation was reproduced through 
Dose with Interplay to be compared with a simple shift 
invariant blurring of the dose the Blurred Dose. We used 
the following formulas for quantifying the impact of interplay 
and range (blurring) effects on dose errors:  
 
Results: Dose errors introduced by the interplay effect 
demonstrated different relationship with the respiration 
amplitude compared to the blurring effects. The errors due 
to interplay effects showed linear relationship with the 
amplitude in all patients. The blurring effect on the other 
side caused dose error with quadratic dependence on the 
amplitude (Figure 1). Our preliminary data also suggest that 
the dose errors due to interplay effects exhibit faster rise 
rate with the amplitude as the tumor size increases. 
 
Conclusions: The dosimetric consequences from the interplay 
and range effects in proton therapy are related to the 
amplitude. Large tumors with higher amplitude of motion 
seem to be more sensitive to dose errors.  
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Purpose/Objective: A high accuracy is crucial in stereotactic 
body radiotherapy (SBRT) treatments, but may be 
compromised by both translations and rotations of the target 
during treatment. While target translations have been 
investigated in detail, only few studies have addressed 
rotations. This study presents the first measurements of 
time-resolved intra-fraction internal target translations and 
rotations during liver SBRT using CBCT projections. 
Materials and Methods: Twenty-seven patients with three 
implanted gold markers received three to six-fraction SBRT 
on a conventional LINAC. One to three CBCT scans were 
acquired during each fraction (186 CBCTs in total). The three 
markers were retrospectively automatically segmented on 
the CBCT projections using in-house developed software. The 
3D trajectory of each marker was estimated using a 
probability based method.  
Intra-fraction translation and rotation of the marker 
constellation with respect to the mean position over the 
whole scan were calculated using Singular Value 
Decomposition (SVD) (Fig 1.). Motion range and Pearson’s 
correlation coefficients (R) per scan between the six degrees 
of freedom were investigated for patients with motion 
amplitude exceeding 1mm.  
Results: Figure 1 shows an example of the time-resolved 
translation and rotation of the marker constellation during a 
CBCT acquisition. Table 1 presents the 2-98 percentile range 
of translation along and rotation around the Right-Left (RL), 
Superior-Inferior (SI) and Anterio-Posterior (AP) axis. The 
motion was the largest in the SI direction (mean range of 
8.93 mm) while the rotation was of similar magnitude around 
all three axes. Rotations higher than 10 degrees were 
occasionally observed. 
The highest correlation was observed between AP and SI 
translations (Fig 1.) with mean R = -0.85 (SD = 0.22). The 
negative correlation means that cranial motion is associated 
with posterior motion. There was significant correlation 
(either positive or negative) between the SI translation and 
RL rotation in general, except for five patients with 
substantial cardiac induced motion for at least one marker 
(gray bars in figure c). Thus cranial motion is associated with 
rotation around the RL axis in either direction, but 
consistently the same direction for the same patient. 
 
 
 
Conclusions: Highly time resolved translations and rotations 
of targets in liver SBRT were determined for the first time on 
a conventional LINAC using CBCT projections. Considerable 
intra-fraction translations and rotations were observed. 
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Correlation of the translation with the rotation may be used 
to optimize the targeting accuracy of marker based liver 
SBRT. Possible optimization includes setup with 6D couch 
corrections, treatment margins aligned to the preferred 
directions of motion, and adaptive treatment techniques such 
as MLC tracking that can compensate for both translations 
and rotations during treatment.  
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Purpose/Objective: The aim of this study was the clinical 
validation of a customized eye tracking system (ETS) for non-
invasive tumor localization and automatic motion detection 
in proton therapy of intraocular tumors.  
Materials and Methods: A prototypal ETS was tested in 
clinical proton therapy at Centre Antoine Lacassagne in Nice 
(FR). The device aims at accurate tumor localization by 
applying 3D infrared video-oculography technique. The 
cornea and pupil centers are recognized on the images 
acquired by two calibrated video cameras, exploiting the eye 
reflections produced by two infrared light sources. This 
allows the assessment of the 3D position and orientation of 
the observed eye. A custom-made calibration chessboard 
fitted with radiopaque beads was used to calibrate the ETS 
and the in-room imaging with respect to the treatment room 
isocenter (fig. 1.a). The direct linear transformation (DLT) 
algorithm was applied to perform geometrical calibration of 
the orthogonal X-Ray system using multiple radiographic 
images of the chessboard. Then, the concurrent localization 
of chessboard corners in ETS images and radiopaque beads in 
X-ray projections allows the calibration of the eye tracker 
(fig. 1.b). The ETS reliability in tumor localization was tested 
during the treatment preparation (fig. 1.c-d) of three eye 
cancer patients for proton irradiation. All of them had 
tantalum markers to localize the target volume. Initial 
patient setup error was estimated by acquiring orthogonal X-
ray images. Then, after applying treatment chair corrections, 
a further acquisition was performed for final setup 
verification. The markers position in the X-ray verification 
images were compared with those estimated by the ETS 
according to the detected eye position and orientation. 
Absolute 3D markers localization error for the entire patient 
cohort is shown in table 1. Moreover, when more than two 
markers were clearly distinguishable in X-ray projections, the 
imposed chair transformation is estimated and compared 
with the ETS observed setup correction. 
 
Results: The mean retro-projection error (± standard 
deviation) for the DLT calibration of the X-ray system was 
0.06±0.03 mm. The 3D error on clips position provided by the 
ETS was measured below 0.75 mm, (tab. 1). Moreover, 
rotations and translations of clips between initial and 
verification X-Ray acquisition, as seen by the ETS and the X-
Ray imaging system, are reported. 
 
 
Conclusions: The ETS prototype provides high accuracy in 
target localization and complies with the high standard 
required in proton therapy of intraocular tumors. Future 
activities will be focused on inter-fraction data acquisition to 
test the ETS accuracy and robustness. 
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Purpose/Objective: Intrafraction tumor motion in scanning 
proton therapy may substantially distort the delivered dose 
distribution. These interplay effects are in particular a 
concern for hypofractionated treatments of liver tumors due 
to the large respiratory motion. Most studies of the interplay 
effect have been based on 4D CT scans and do not include 
irregular breathing. In contrast, this study use real 3D organ 
motions recorded during actual treatments. We establish a 
method to calculate the dose delivered to moving targets in 
scanning proton therapy by a commercial treatment planning 
system (TPS), and apply this method to investigate interplay 
effects for a number of liver SBRT patients with known tumor 
motion. 
Materials and Methods: Two three-field scanning proton 
plans (IMPT and single-field-optimization (SFO)) with 4mm 
spot spacing and a mean GTV dose of 18.75Gy per fraction 
were created for sixteen patients who were previously 
treated with three-fraction x-ray SBRT on a linear 
